- Home
- IVDA vs NLSP Comparison
IVDA vs NLSP Comparison
Compare IVDA & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- NLSP
- Stock Information
- Founded
- IVDA 2003
- NLSP 2015
- Country
- IVDA United States
- NLSP Switzerland
- Employees
- IVDA N/A
- NLSP N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- NLSP Health Care
- Exchange
- IVDA Nasdaq
- NLSP Nasdaq
- Market Cap
- IVDA 3.5M
- NLSP 243.8M
- IPO Year
- IVDA N/A
- NLSP 2021
- Fundamental
- Price
- IVDA $1.64
- NLSP $4.96
- Analyst Decision
- IVDA
- NLSP
- Analyst Count
- IVDA 0
- NLSP 0
- Target Price
- IVDA N/A
- NLSP N/A
- AVG Volume (30 Days)
- IVDA 40.0K
- NLSP 34.6K
- Earning Date
- IVDA 11-20-2024
- NLSP 11-01-2024
- Dividend Yield
- IVDA N/A
- NLSP N/A
- EPS Growth
- IVDA N/A
- NLSP N/A
- EPS
- IVDA N/A
- NLSP N/A
- Revenue
- IVDA $3,779,754.00
- NLSP N/A
- Revenue This Year
- IVDA $23.76
- NLSP N/A
- Revenue Next Year
- IVDA $229.89
- NLSP N/A
- P/E Ratio
- IVDA N/A
- NLSP N/A
- Revenue Growth
- IVDA N/A
- NLSP N/A
- 52 Week Low
- IVDA $1.40
- NLSP $4.08
- 52 Week High
- IVDA $10.16
- NLSP $29.68
- Technical
- Relative Strength Index (RSI)
- IVDA 41.96
- NLSP 46.37
- Support Level
- IVDA $1.40
- NLSP $4.52
- Resistance Level
- IVDA $1.72
- NLSP $5.64
- Average True Range (ATR)
- IVDA 0.10
- NLSP 0.48
- MACD
- IVDA 0.06
- NLSP 0.07
- Stochastic Oscillator
- IVDA 75.00
- NLSP 55.44
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.